24 related articles for article (PubMed ID: 15081086)
1. Plasma and cerebrospinal fluid concentrations of indomethacin in children after intravenous administration.
Mannila A; Kumpulainen E; Lehtonen M; Heikkinen M; Laisalmi M; Salo T; Rautio J; Savolainen J; Kokki H
J Clin Pharmacol; 2007 Jan; 47(1):94-100. PubMed ID: 17192507
[TBL] [Abstract][Full Text] [Related]
2. Entry of the new quinolone antibacterial agents of ofloxacin and NY-198 into the central nervous system in rats.
Sato H; Okezaki E; Yamamoto S; Nagata O; Kato H; Tsuji A
J Pharmacobiodyn; 1988 Jun; 11(6):386-94. PubMed ID: 3171880
[TBL] [Abstract][Full Text] [Related]
3. Mode of administration-dependent brain uptake of indomethacin: sustained systemic input increases brain influx.
Dahan A; Hoffman A
Drug Metab Dispos; 2007 Feb; 35(2):321-4. PubMed ID: 17142563
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of ciprofloxacin XR (1000 mg) versus levofloxacin (500 mg) in plasma and urine of male and female healthy volunteers receiving a single oral dose.
Wagenlehner FM; Kinzig-Schippers M; Tischmeyer U; Wagenlehner C; Sörgel F; Dalhoff A; Naber KG
Int J Antimicrob Agents; 2006 Jan; 27(1):7-14. PubMed ID: 16343856
[TBL] [Abstract][Full Text] [Related]
5. Two open-label, randomized, crossover studies assessing the bioequivalence of ofloxacin administered as immediate-and extended-release formulations in healthy subjects.
Marier JF; Ducharme MP; DiMarco M; Di Spirito M; Morelli G; Tippabhotla SK; Badri N; Rampal A; Monif T
Clin Ther; 2006 Dec; 28(12):2070-80. PubMed ID: 17296463
[TBL] [Abstract][Full Text] [Related]
6. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
7. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
8. Prediction of brain delivery of ofloxacin, a new quinolone, in the human from animal data.
Kawakami J; Yamamoto K; Sawada Y; Iga T
J Pharmacokinet Biopharm; 1994 Jun; 22(3):207-27. PubMed ID: 7884650
[TBL] [Abstract][Full Text] [Related]
9. [Quinolones and their central nervous system toxicities].
Hori S; Kageyama S
Ryoikibetsu Shokogun Shirizu; 1999; (27 Pt 2):552-7. PubMed ID: 10434720
[No Abstract] [Full Text] [Related]
10. Clinical pharmacokinetics of nonsteroidal anti-inflammatory drugs in the cerebrospinal fluid.
Bannwarth B; Netter P; Pourel J; Royer RJ; Gaucher A
Biomed Pharmacother; 1989; 43(2):121-6. PubMed ID: 2660917
[TBL] [Abstract][Full Text] [Related]
11. The influence of indomethacin co-administration on ofloxacin levels in plasma and cerebrospinal fluid in rats.
Dontas I; Sokolis DP; Giamarellos-Bourboulis EJ; Tzonou A; Giamarellou H; Karayannacos PE
Int J Antimicrob Agents; 2004 Apr; 23(4):371-6. PubMed ID: 15081086
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
